Rare Disease Equity
Advancing Equity in Rare Disease Trials: Global Realities, Local Solutions
Rose Blackburne, M.D., MBA; Radojica Savic, M.D.; Galina Nesterova, MD
PPD clinical research business of Thermo Fisher Scientific
PAO-05-25-CL-02Jul 23, 2025
Clinical Platforms
Why Clinical Trial Platforms Must Evolve from Tools to Strategy
Chris Driver
IQVIA
PAO-07-25-CL-03Jul 18, 2025
Marketing
What Biotech and Pharma Buyers Actually Care About and How to Market Accordingly
Emilee Kudla
Pharma's Almanac
PAO-06-25-NI-06Jun 16, 2025
Recruitment
Bringing Clinical Trial Enrollment to the Point of Diagnosis
Tim Rich; Matt Schwartz
PPD clinical research business of Thermo Fisher Scientific
PAO-04-25-CL-01Apr 28, 2025
Anniversary
Nelson Labs Celebrates 40 Years of Excellence in Science and Service
Nelson Labs
PR-04-25-NI-04Apr 17, 2025
Particle Analysis
Advancing Subvisible Particle Characterization with Artificial Intelligence
Daniel Weinbuch, Ph.D.
Coriolis Pharma
PAO-03-25-CL-02Mar 11, 2025
Manufacturing
Advanced Pharmaceutical Manufacturing Concepts Are Quickly Becoming Realities
Tonia Becker; RECONNEX 365
Nice Insight
PAO-02-25-CL-05Feb 10, 2025
Future Medicines
How Today’s Pharmaceutical Industry is Transforming to Support the Medicines of the Future
Tonia Becker; RECONNEX 365
Nice Insight
PAO-02-25-CL-04Feb 06, 2025
Developability
Streamlining Drug Development with Integrated In Silico and Laboratory Developability Assessments
Andrea Arsiccio, Ph.D.,; Eva Keilhauer, Ph.D.; Kristian Le Vay, Ph.D.
Coriolis Pharma
PAO-01-25-CL-12Jan 27, 2025
Large Molecule
Managing Pharmacovigilance Challenges for Biosimilars
Ivana Lisec, MPharm
PrimeVigilance
PAO-11-24-CL-05Jan 02, 2025
CRO
Lindus Health Rolls Out "All-in-One Infectious Disease CRO" Bespoke to Clinical Trials for Infectious Disease Interventions
Lindus Health
PR-11-24-NI-113Nov 19, 2024
Particle ID
Leveraging Formulation Development Experience for Effective Particle Identification
Jörg Müller, Ph.D.
Coriolis Pharma
PAO-10-24-CL-10Nov 18, 2024
Precision Medicine
Advancing Personalized Medicines and Precision Therapeutics
Thermo Fisher Scientific
PAO-11-24-RTM-10Nov 15, 2024
Bioassays
State-of-the-Art, Multi-Modality Bioanalysis in Brisbane
Resolian
PAO-11-24-RTM-04Nov 12, 2024
Clinical Trials
ProPharma Group is Supporting Better Clinical Outcomes Down Under
ProPharma
PAO-10-24-RTM-05Nov 04, 2024
Clinical Trials
Passion and Understanding Essential for Rare Disease Clinical Trials
Juliet Moritz
Ergomed
PAO-10-24-CL-03Oct 29, 2024
Oncology Trials
Navigating the Complex Landscape of Oncology Trials
Colin Hayward, MB BS
Ergomed
PAO-10-24-CL-04Oct 22, 2024
Appointment
Bio X Cell Announces Board of Director Appointments
Bio X Cell
PR-10-24-NI-45Oct 17, 2024
Commercialization
Development Strategies for Overcoming Commercialization Challenges
Matthias Lucke, Ph.D.
Coriolis Pharma
PAO-09-24-CL-10Sep 17, 2024
Ophthalmology
The Shift from Early- to Late-Phase Ophthalmology Retina Market in 2024: Proactive Planning for Late-Stage Clinical Success
Tracey Roberts, MSHS; Jennifer Christiansen, Ph.D.; Debra Schaumberg, Sc.D., O.D., M.P.H.
PPD clinical research business of Thermo Fisher Scientific
PAO-08-24-CL-05Sep 16, 2024